Jared L. Crandon

Clinical Pharmacodynamics of Cefepime in Patients Infected with <i>Pseudomonas aeruginosa</i>

Jared L. Crandon, Catharine C. Bulik, Joseph L. Kuti et al. · Antimicrobial Agents and Chemotherapy · 2009 · 120 citations · Full text

Antimicrobial Chemotherapy, Cefepime Therapy, Bacterial Pathogens +18

Population Pharmacokinetics of High-Dose, Prolonged-Infusion Cefepime in Adult Critically Ill Patients with Ventilator-Associated Pneumonia

Anthony M. Nicasio, Robert E. Ariano, Sheryl Zelenitsky et al. · Antimicrobial Agents and Chemotherapy · 2009 · 119 citations · Full text

Nephrology, Population Pharmacokinetics, Physiologically-based Pharmacokinetic Modeling +17

Comparative <i>In Vitro</i> and <i>In Vivo</i> Efficacies of Human Simulated Doses of Ceftazidime and Ceftazidime-Avibactam against Pseudomonas aeruginosa

Jared L. Crandon, Virna Schuck, Mary Anné Banevicius et al. · Antimicrobial Agents and Chemotherapy · 2012 · 115 citations · Full text

Adaptation-Based Resistance to Siderophore-Conjugated Antibacterial Agents by Pseudomonas aeruginosa

Andrew P. Tomaras, Jared L. Crandon, Craig J. McPherson et al. · Antimicrobial Agents and Chemotherapy · 2013 · 110 citations · Full text

Human Simulated Studies of Aztreonam and Aztreonam-Avibactam To Evaluate Activity against Challenging Gram-Negative Organisms, Including Metallo-β-Lactamase Producers

Jared L. Crandon, David P. Nicolau · Antimicrobial Agents and Chemotherapy · 2013 · 103 citations · Full text

Antimicrobial Chemotherapy, Metallo-β-lactamase Producers, Bacterial Pathogens +20